Coferon
Coferon employs bioorthogonal linker chemistry to deliver therapeutic molecules in component parts that self assembles inside target cells.
Launch date
Employees
Market cap
-
Enterprise valuation
€44—65m (Dealroom.co estimates Jul 2012.)
Town of Brookhaven New York (HQ)
Authorizing premium user...